Journal Information
Vol. 79. Issue 2.
Pages 132 (March - April 2013)
Share
Share
Download PDF
More article options
Vol. 79. Issue 2.
Pages 132 (March - April 2013)
Editorial
Open Access
Steroid use in laryngeal diseases
Visits
4331
Regina Martins
Senior Associate Professor of Otorhinolaryngology - Medical School of Botucatu (UNESP); and Coordinator of the Graduate Program in Surgery
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

In our specialty, steroids are commonly used to treat laryngeal disorders, by different routes of administration; however, in many clinical conditions we still lack scientific evidence enough to prove the benefits of such treatment, as well as the most adequate doses and the best routes for administration. For some laryngeal diseases - such as the supraglottitis, the use of steroids is undisputed - precluding tracheal intubation in adults and children alike. There are some systematic reviews in the literature proving the efficacy of oral dexamethasone and inhaled budesonide or fluticasone propionate in the treatment of supraglottitis1,2. Many of these review papers include randomized trials and provide a more reliable assessment based on large samples. Some authors consider the inhalation route as efficient as the oral or intramuscular injection in the treatment of acute inflammatory laryngitis; however, there are those who advocate the oral route of administration as more efficacious. The authors also agree that the side effects of inhaled steroids are less pronounced vis-à -vis those used by other routes.

Another precise clinical indication for steroids is in laryngotracheobronchitis, which involves subglottic edema which often times extends to the tracheobronchial tree. Symptoms of cough, stridor and dyspnea may be minimized with the use of inhaled steroids (budesonide) - considered an efficient and safe treatment.

Steroid indication to prevent post-intubation stridor has also been approached by some systematic review papers and, in such clinical conditions, the intravenous route is the most utilized one. These studies show a trend towards a reduction in the number of re-intubations of newborns, proven reduction in older children, and the lack of evidence that these drugs benefit adult patients3,4.

Another very frequent use of steroids is in the course of acute viral laryngitis, especially in people who make professional use of their voices (voice professionals) - singers and actors, who require a quick recovery from their symptoms to return to their professional activities as soon as possible. The steroids used in these cases are usually administered via intramuscular injection (betamethasone) or inhaled5.

Despite better patient compliance concerning inhaled treatment, one must stress that it is not free from side effects. Inhaled steroids are commonly used in asthmatic patients, and many of them use the medication day-in day-out for many months. Drug particles, as dry powder, settle along the airway mucosae, and this may cause local irritation, characterizing a form of chemical laryngitis, peaking as inflammation of the airway mucosae. We also notice erythema, mucosal edema, thickening, leukoplasia, granulation tissue and candidiasis6,7. The most common symptoms are dysphonia, pain and a burning sensation upon swallowing. These side effects may have negative repercussions on the vocal performance of voice processionals, and symptom improvement is associated with drug-treatment interruption. Thus, these professionals prefer injectable steroids.

Inhaled or intra-lesion steroids have been also used in the remission of some benign lesions of the vocal folds, such as granulomas, nodules and polyps8.

REFERENCES
[1]
Russell K , Wiebe N , Saenz A , Ausejo SM , Johnson D , Hartling L , Klassen TP. .
Glucocorticoids for croup.
Cochrane Database Syst Rev, (2004), pp. CD001955
[2]
Riffat F , Jefferson N , Bari N , McGuinness J. .
Acute supraglottitis in adults.
Ann Otol Rhinol Laryngol, 120 (2011), pp. 296-299
[3]
Markovitz BP , Randolph AG. .
Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults.
Cochrane Database Syst Rev, (2000), pp. CD001000
[4]
Khemani RG , Randolph A , Markovitz B. .
Steroids for post extubation stridor: pediatric evidence is still inconclusive.
Intensive Care Med, 36 (2010), pp. 1276-1277
[5]
Kriukov AI , Romanenko SG , Pavlikhin OG , Eliseev OV. .
Inhalation therapy of laryngeal inflammation.
Vestn Otorinolaringol, (2008), pp. 53-55
[6]
Malton A , DeFatta RA , Sataloff RT. .
Acute candidal pharyngolaryngitis.
Ear Nose Throat J., 91 (2012), pp. E31-E32
[7]
Hillel AT , Lin LM , Samlan R , Starmer H , Leahy K , Flint PW. .
Inhaled triamcinolone with proton pump inhibitor for treatment of vocal process granulomas: a series of 67 granulomas.
Ann Otol Rhinol Laryngol, 119 (2010), pp. 325-330
[8]
Tateya I. .
Laryngeal steroid injection.
Curr Opin Otolaryngol Head Neck Surg, 17 (2009), pp. 424-426
Copyright © 2013. Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial
Idiomas
Brazilian Journal of Otorhinolaryngology (English Edition)
Article options
Tools
en pt
Announcement Nota importante
Articles submitted as of May 1, 2022, which are accepted for publication will be subject to a fee (Article Publishing Charge, APC) payment by the author or research funder to cover the costs associated with publication. By submitting the manuscript to this journal, the authors agree to these terms. All manuscripts must be submitted in English.. Os artigos submetidos a partir de 1º de maio de 2022, que forem aceitos para publicação estarão sujeitos a uma taxa (Article Publishing Charge, APC) a ser paga pelo autor para cobrir os custos associados à publicação. Ao submeterem o manuscrito a esta revista, os autores concordam com esses termos. Todos os manuscritos devem ser submetidos em inglês.